| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |